Long-Term Maintenance of Improvements in Multiple Facets of Psoriatic Arthritis with Certolizumab Pegol- 48-Week Patient-Reported Outcome Results of the Rapid-PsA Study
Abstract
Authors
D. Gladman R. Fleischmann G. Coteur L. Peterson P.J. Mease